ZEMA Pharma Consulting ApS: Financial statements 2025
CVR: 42680427
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
ZEMA Pharma Consulting ApS (CVR 42680427) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. That is a decrease of 21.8% compared with the year before. Equity in the 2025 report amounted to DKK 354,543. The solvency ratio was 44.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 102,227
- Profit/Loss
- DKK -216,744
- Equity
- DKK 354,543
- Total Assets
- DKK 788,913
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 102K | -217K | 355K | 1 |
| 2024 | - | 131K | -282K | 571K | 1 |
| 2023 | - | 1.5M | 812K | 853K | 1 |
| 2022 | - | 1.1M | 790K | 830K | 1 |
Official annual report
How creditworthy is ZEMA Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout ZEMA Pharma Consulting ApS
ZEMA Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Torkild Hansen. The company is owned by Mads Torkild Hansen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. Equity in the 2025 report amounted to DKK 354,543.
